Treating patients with overactive bladder syndrome with antimuscarinics: heart rate considerations

被引:22
|
作者
Andersson, Karl-Erik
Olshansky, Brian
机构
[1] Wake Forest Univ, Bowman Gray Sch Med, Wake Forest Inst Regenerat Med, Winston Salem, NC 27157 USA
[2] Univ Iowa Hosp, Iowa City, IA USA
关键词
heart rate; muscarinic receptors; antimuscarinics; overactive bladder; cardiac disease;
D O I
10.1111/j.1464-410X.2007.07100.x
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1007 / 1014
页数:8
相关论文
共 50 条
  • [41] Considering the Effect of Combining α-Blockers With Bladder Antimuscarinics in Treatment of Overactive Bladder Symptoms
    Bahat, Gulistan
    Gunaydin, Senay
    Karan, Mehmet Akif
    JAMA INTERNAL MEDICINE, 2020, 180 (07) : 1025 - 1025
  • [42] Heart rate variability in overactive bladder experimental model
    Dobrek, Lukasz
    Thor, Piotr
    ARCHIVES OF MEDICAL SCIENCE, 2013, 9 (05) : 930 - 935
  • [43] Treating overactive bladder in the elderly
    Wagg, Adrian
    CUAJ-CANADIAN UROLOGICAL ASSOCIATION JOURNAL, 2011, 5 (03): : S149 - S151
  • [44] Treatment of Overactive Bladder in Elderly Patients: Clinical Considerations
    Padilla-Fernandez, Barbara
    Hernandez-Hernandez, David
    Morgenstern, Saskia C.
    Concepcion Masip, Tomas
    Castro-Diaz, David M.
    CLINICAL MEDICINE INSIGHTS-GERIATRICS, 2015, 8 : 11 - 20
  • [45] COST-EFFECTIVENESS OF MIRABEGRON COMPARED WITH ANTIMUSCARINICS FOR THE TREATMENT OF PATIENTS WITH OVERACTIVE BLADDER IN THE UNITED KINGDOM
    Maman, K.
    Neine, M.
    Briquet, B.
    Nazir, J.
    Odeyemi, I. A. O.
    Hakimi, Z.
    Garnham, A.
    Aballea, S.
    VALUE IN HEALTH, 2013, 16 (07) : A633 - A634
  • [46] Economic considerations in overactive bladder
    Hu, TW
    Wagner, TH
    AMERICAN JOURNAL OF MANAGED CARE, 2000, 6 (11): : S591 - S598
  • [47] Antimuscarinics for the treatment of overactive bladder: understanding the role of muscarinic subtype selectivity
    Glavind, Karin
    Chancellor, Michael
    INTERNATIONAL UROGYNECOLOGY JOURNAL, 2011, 22 (08) : 907 - 917
  • [48] Antimuscarinics for the treatment of overactive bladder: A review of central nervous system effects
    Klausner A.P.
    Steers W.D.
    Current Bladder Dysfunction Reports, 2008, 3 (3) : 161 - 167
  • [49] Antimuscarinics for the treatment of overactive bladder: A review of central nervous system effects
    Klausner A.P.
    Steers W.D.
    Current Urology Reports, 2007, 8 (6) : 441 - 447
  • [50] Comparative safety of antimuscarinics versus mirabegron for overactive bladder in Parkinson disease
    Abraham, Danielle S.
    Nguyen, Thanh Phuong Pham
    Newcomb, Craig W.
    Gray, Shelly L.
    Hennessy, Sean
    Leonard, Charles E.
    Liu, Qing
    Weintraub, Daniel
    Willis, Allison W.
    PARKINSONISM & RELATED DISORDERS, 2023, 115